세계의 전기 의료 및 생체 전기 의료 시장 : 제품(심장 페이스메이커, ICD, 인공 내이, 신경 조절), 유형, 용도별 예측(-2029년)

Electroceuticals/Bioelectric Medicine Market by Product (Cardiac Pacemakers, ICD, Cochlear Implant, Neuromodulation ), Type, Application - Global Forecast to 2029

US $ 4,950 ￦ 6,884,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 6,650 ￦ 9,248,000

PDF (5-user License)

PDF 보고서를 동일 사업장에서 5명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 8,150 ￦ 11,335,000

PDF (Corporate License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 이용 인원에 제한은 없으나, 국내에 있는 사업장만 해당되며, 해외 지점 등은 포함되지 않습니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 10,000 ￦ 13,908,000

PDF (Global License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. (100% 자회사는 동일 기업으로 간주됩니다.) 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

전기 의료 및 생체 전기 의료 및 생체 전기 의료 규모는 예측 기간 동안 복합 연간 성장률(CAGR) 7.0%로 추이되며 2024년 239억 달러에서 2029년 336억 달러 규모에 달할 것으로 예측됩니다.

이 시장 성장의 주요 요인으로는 심장 리듬 관리(CRM) 장치의 연구 투자 및 자금 투입 증가, 신경 질환에 대한 정부 지원 및 자금 제공 증가, 신경 질환 및 심혈관 질환 유병 비율의 상승으로 이어지는 노령 인구 증가 등을 들 수 있습니다. 한편, 전기 의료 장치의 비용이 높고, 엄청난 설비 투자가 필요하다는 것은 시장 성장을 억제하고 있습니다.

조사 범위
조사 대상년도	2021-2029년
기준년	2023년
예측 기간	2024년-2029년
단위	금액(달러)
부문	제품 유형, 용도 및 지역별
대상 지역	북미, 유럽, 아시아태평양, 라틴아메리카, 중동 & 아프리카

예측 기간 동안 망막 이식 부서가 최대 성장률을 보여줄 전망 :

망막 이식는 망막 색소 변성 및 노화 황반 변성과 같은 망막 변성 질환 환자의 시력을 회복시킬 수 있으며 성장이 촉진되고 있습니다.

비침습 전자 슈팅 장치의 부서가 예측 기간 동안 가장 높은 수익 성장률을 보여줄 전망:

이러한 장치는 외과적 이식을 필요로 하지 않으며, 대신에 전계와 자기장을 사용하여 신체 표면의 신경과 근육을 자극합니다. 사용하기 쉽고 비용 효과적이며 감염 위험도 낮습니다. 비침습 일렉트로슈티칼스는 만성 통증, 신경 장애, 대사 장애의 치료에 점점 더 많이 사용되고 있습니다. 이 장치의 기술 진보와 의료 지출 증가와 만성 질환의 유병률의 상승도 예측 기간 동안의 성장을 가속할 것으로 예상됩니다.

아시아태평양이 가장 성장하는 지역에 :

아시아태평양은 예측 기간 동안 가장 높은 복합 연간 성장률(CAGR) 기록할 것으로 예상됩니다. 이 성장은 의료 지출 증가, 약물 R&D 증가, 질병 조기 발견에 대한 의식 향상을 위한 정부의 이니셔티브, 각국의 농촌로의 민간 병원 확대, 지역 내 고성장 시장 존재 등 요인 때문입니다.

본 보고서에서는 세계 일렉트로슈티컬스/생체전기의료 시장을 조사했으며,, 시장 개요, 시장영향인자 및 시장 기회 분석, 기술,특허 동향, 법규제 환경, 시장 규모 추이와 예측, 각종 구분,지역별 상세 분석, 경쟁 구도, 주요 기업 프로파일 등을 정리했습니다.

목차

제1장 서론

제2장 조사 방법

제3장 주요 요약

제4장 중요 인사이트

제5장 시장 개요

• 시장 역학
  • 성장 촉진요인
  • 억제요인
  • 기회
  • 과제
  • 동향
• 가격 분석
• 밸류체인 분석
• 공급망 분석
• 생태계 분석
• Porter's Five Forces 분석
• 규제 상황
• 기술 분석
• 무역 분석
• 특허 분석
• 주요 회의 및 이벤트
• 고객의 비즈니스에 영향을 미치는 동향/혁신
• 주요 이해관계자와 구매 기준

제6장 전기 의료 및 생체 전기 의료 시장 : 제품별

• 심장 페이스메이커 및 이식형 제세동기
• 인공 내이
• 신경조절물질
  • 척수 자극 장치
  • 심부뇌자극장치
  • 미주 신경 자극 장치
  • 천골 신경 자극제
  • 위 전기 자극 장치
  • 경피적 전기신경자극장치
  • 경두개 자기 자극기
  • 호흡기 전기자극장치
  • 미샤 신경 자극제
  • 반응성 신경 자극 물질
• 망막 이식

제7장 전기 의료 및 생체 전기 의료 시장 : 유형별

• 임베디드 일렉트로슈티컬 디바이스
• 비침습 일렉트로슈티컬 디바이스

제8장 전기 의료 및 생체 전기 의료 시장 : 용도별

• 심장 페이스메이커 및 ICD용 : 용도별
  • 부정맥
  • 심부전
  • 기타
• 척수 자극기용 : 용도별
  • 만성 통증
  • 허리 수술 실패 증후군
  • 허혈
• 심부뇌자극장치용 : 용도별
  • 파킨슨병
  • 떨림
  • 우울
  • 기타
• 천골신경자극장치용 : 용도별
  • 요실금
  • 편실금
• 미주 신경 자극기용 : 용도별
  • 간질
  • 기타
• 위 전기 자극기용 : 용도별
  • 위부전 마비
  • 비만
• 경피적 전기 신경 자극기용 : 용도별
  • 치료 저항성 우울증
  • 기타
• 경두개 자기 자극기용 : 용도별
  • 우울
  • 편두통
• 호흡기 전기 자극기용 : 용도별
  • 척수 손상
• 3차 신경 자극기용 : 용도별
  • 주의 결함/다동성 장애
  • 편두통

제9장 전기 의료 및 생체 전기 의료 시장 : 지역별

• 북미
• 유럽
• 아시아태평양
• 라틴아메리카
• 중동 및 아프리카

제10장 경쟁 구도

• 개요
• 주요 기업의 채용 전략/유력 기업
• 수익 분석
• 시장 점유율 분석
• 브랜드/제품 비교
• 기업 평가 매트릭스 : 주요 기업
• 기업 실적
• 기업 평가 매트릭스 : 스타트업/중소기업
• 경쟁 벤치마킹
• 경쟁 시나리오

제11장 기업 프로파일

• 주요 기업
  • MEDTRONIC
  • BOSTON SCIENTIFIC CORPORATION
  • ABBOTT
  • LIVANOVA PLC
  • COCHLEAR LTD.
  • MICROPORT SCIENTIFIC CORPORATION
  • SONOVA
  • NEVRO CORP.
  • AXONICS, INC.
  • NEURONETICS
  • ELECTROCORE, INC.
  • NEUROPACE, INC.
• 기타 기업
  • BIOTRONIK
  • MEDICO SRL
  • ZHEJIANG NUROTRON BIOTECHNOLOGY CO., LTD.
  • MED-EL
  • ALEVA NEUROTHERAPEUTICS
  • NEUROSIGMA, INC.
  • BIOWAVE CORPORATION
  • SOTERIX MEDICAL INC.
  • BIOINDUCTION(AMBER THERAPEUTICS)
  • GIMER MEDICAL
  • CEFALY
  • BIOCONTROL MEDICAL
  • TVNS HEALTH GMBH

제12장 부록

BJH

영문 목차

영문목차

The global market for electroceuticals/bioelectric medicine is expected to grow to USD 33.6 billion by 2029, up from USD 23.9 billion in 2024, representing a CAGR of 7.0% during the forecast period. This growth is being primarily driven by several factors, including increased investments and funding for research on cardiac rhythm management (CRM) devices, rising government support and funding for neurological disorders, and the growing geriatric population, which is leading to a higher prevalence of neurological and cardiovascular disorders. However, the market's growth is being hindered by the high cost of electroceutical devices and the need for significant capital investments.

Scope of the Report
Years Considered for the Study	2021-2029
Base Year	2023
Forecast Period	2024-2029
Units Considered	Value (USD) Billion
Segments	Product, type, application, and region
Regions covered	North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa

"The retinal implants segment accounted for the highest growth rate in the electroceuticals market, by product, during the forecast period"

Based on product, the electroceuticals market is segmented into cardiac pacemakers & implantable cardioverter defibrillators, neuromodulators, cochlear implants, and retinal implants. In 2022, the retinal implants segment accounted for the highest growth rate in the electroceuticals market. The main driving factor for retinal implants is the potential to restore vision in individuals with retinal degenerative diseases such as retinitis pigmentosa and age-related macular degeneration.

"The non-invasive electroceuticals devices segment is projected to experience the highest revenue growth rate during the forecast period"

The electroceuticals market is divided into two segments: implantable electroceutical devices and non-invasive electroceutical devices. In 2022, the noninvasive electroceutical devices segment experienced the highest growth rate. These devices do not require surgical implantation; instead, they use electrical or magnetic fields to stimulate nerves or muscles on the body's surface. They are easy to use, cost-effective, and carry a lower risk of infection. Non-invasive electroceuticals are increasingly being used in the treatment of chronic pain, neurological disorders, and metabolic disorders. Technological advancements in non-invasive electroceuticals, along with increased healthcare expenditure and a rise in the prevalence of chronic diseases, are anticipated to drive the growth of the non-invasive devices segment in the forecast period.

"Asia Pacific: The fastest-growing region in electroceuticals care market"

The global electroceuticals market is divided into North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. The Asia Pacific region is expected to record the highest CAGR during the forecast period. This growth is attributed to factors such as increased healthcare expenditure, rising pharmaceutical research funding, government initiatives to raise awareness about early disease detection, expansion of private-sector hospitals into rural areas in various APAC countries, and the presence of high-growth markets in the region.

The primary interviews conducted for this report can be categorized as follows:

• By Company Type: Tier 1 - 28%, Tier 2 - 42%, and Tier 3 -30%
• By Designation: C-level - 30%, D-level - 34%, and Others - 36%
• By Region: North America - 46%, Europe - 25%, Asia Pacific - 18%, and Rest of the World -11%

Lists of Companies Profiled in the Report:

• Medtronic plc (Ireland)
• Boston Scientific Corporation (US)
• Abbott Laboratories, Inc. (US)
• Cochlear Ltd. (Australia)
• LivaNova PLC (UK)
• MicroPort Scientific Corporation (China)
• Sonova Group (Switzerland)
• Nevro Corp. (US)
• Axonics Modulation Technologies, Inc. (US)
• Neuronetics, Inc. (US)
• ElectroCore, Inc. (US)
• NeuroPace, Inc. (US)
• BIOTRONIK (Germany)
• Medico S.p.A. (Italy)
• Nurotron Biotechnology Co. Ltd. (US)
• MED-EL (Austria)
• Aleva Neurotherapeutics SA (Switzerland)
• NeuroSigma, Inc. (US)
• BioWave Corporation (US)
• Soterix Medical Inc. (US)
• Bioinduction (Amber Therapeutics) (UK)
• GiMer Medical (Taiwan)
• Cefaly (Belgium)
• BioControl Medical (Israel)
• tVNS Technologies GmbH (Germany).

Research Coverage:

This research report categorizes the electroceuticals market by products, type, application and region. The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the electroceuticals market. A detailed analysis of the key industry players has been done to provide insights into their business overview, solutions, key strategies; contracts, partnerships, agreements, new product launches, mergers and acquisitions, and recent developments associated with the electroceuticals market. Competitive analysis of upcoming startups in the electroceuticals market ecosystem is covered in this report.

Key Benefits of Buying the Report:

The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall electroceuticals market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, challenges, and opportunities.

The report provides insights on the following pointers:

• Analysis of key drivers, restraints, opportunities, and challenges influencing the growth of the electroceuticals market.
• Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product launches in the electroceuticals market.
• Market Development: Comprehensive information about lucrative markets - the report analyses the electroceuticals market across varied regions.
• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the electroceuticals market.
• Competitive Assessment: In-depth assessment of market ranking, growth strategies and product offerings of leading players like Medtronic plc (Ireland), Boston Scientific Corporation (US), Abbott Laboratories, Inc. (US), and Cochlear Ltd. (Australia) among others in the electroceuticals market strategies.

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 STUDY OBJECTIVES
• 1.2 MARKET DEFINITION
  • 1.2.1 INCLUSIONS & EXCLUSIONS OF STUDY
• 1.3 STUDY SCOPE
  • FIGURE 1 ELECTROCEUTICALS MARKET SEGMENTATION
  • 1.3.1 GEOGRAPHIC SCOPE
  • 1.3.2 YEARS CONSIDERED
• 1.4 CURRENCY
• 1.5 LIMITATIONS
• 1.6 STAKEHOLDERS
• 1.7 SUMMARY OF CHANGES
  • 1.7.1 RECESSION IMPACT

2 RESEARCH METHODOLOGY

• 2.1 RESEARCH DATA
  • FIGURE 2 RESEARCH DESIGN
  • 2.1.1 SECONDARY DATA
    • 2.1.1.1 Key data from secondary sources
  • 2.1.2 PRIMARY DATA
    • 2.1.2.1 Key data from primary sources
    • 2.1.2.2 Key industry insights
  • TABLE 1 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
  • FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY END USER, DESIGNATION, AND REGION
• 2.2 MARKET SIZE ESTIMATION
  • 2.2.1 BOTTOM-UP APPROACH
  • FIGURE 5 MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH (COMPANY REVENUE ESTIMATION APPROACH)
  • FIGURE 6 MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH (SEGMENTAL REVENUE ESTIMATION APPROACH)
  • FIGURE 7 MARKET SIZE ESTIMATION: TOP-DOWN APPROACH
  • FIGURE 8 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
• 2.3 MARKET BREAKDOWN & DATA TRIANGULATION
  • FIGURE 9 DATA TRIANGULATION METHODOLOGY
• 2.4 MARKET SHARE ANALYSIS
• 2.5 ASSUMPTIONS
• 2.6 RISK ASSESSMENT
  • TABLE 2 RISK ASSESSMENT: ELECTROCEUTICALS MARKET
• 2.7 LIMITATIONS
  • 2.7.1 METHODOLOGY-RELATED LIMITATIONS
  • 2.7.2 SCOPE-RELATED LIMITATIONS
• 2.8 IMPACT OF RECESSION ON ELECTROCEUTICALS MARKET

3 EXECUTIVE SUMMARY

• FIGURE 10 ELECTROCEUTICALS MARKET, BY PRODUCT, 2024 VS. 2029 (USD MILLION)
• FIGURE 11 ELECTROCEUTICALS MARKET, BY TYPE, 2024 VS. 2029 (USD MILLION)
• FIGURE 12 ELECTROCEUTICALS MARKET FOR CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY APPLICATION, 2024 VS. 2029 (USD MILLION)
• FIGURE 13 ELECTROCEUTICALS MARKET, BY REGION, 2024 VS. 2029 (USD MILLION)

4 PREMIUM INSIGHTS

• 4.1 ELECTROCEUTICALS MARKET OVERVIEW
  • FIGURE 14 RISING PREVALENCE OF NEUROLOGICAL AND CARDIOVASCULAR DISORDERS TO DRIVE MARKET
• 4.2 ELECTROCEUTICALS MARKET SHARE, BY PRODUCT, 2024 VS. 2029
  • FIGURE 15 CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS WILL CONTINUE TO DOMINATE MARKET IN 2029
• 4.3 ELECTROCEUTICALS MARKET SHARE, BY TYPE, 2024 VS. 2029
  • FIGURE 16 IMPLANTABLE ELECTROCEUTICAL DEVICES TO DOMINATE MARKET IN 2024
• 4.4 ELECTROCEUTICALS MARKET SHARE FOR CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY APPLICATION, 2024 VS. 2029
  • FIGURE 17 ARRHYTHMIA SEGMENT TO DOMINATE MARKET IN 2029
• 4.5 ELECTROCEUTICALS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
  • FIGURE 18 ASIA PACIFIC TO REGISTER HIGHEST GROWTH IN ELECTROCEUTICALS MARKET DURING FORECAST PERIOD

5 MARKET OVERVIEW

• 5.1 INTRODUCTION
• 5.2 MARKET DYNAMICS
  • FIGURE 19 ELECTROCEUTICALS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • 5.2.1 DRIVERS
    • 5.2.1.1 Rising geriatric population and subsequent growth in prevalence of neurological and cardiovascular disorders
    • 5.2.1.2 Rising government support and funding for neurological disorders
    • 5.2.1.3 Increasing investments and funding for research on CRM devices
    • 5.2.1.4 Increasing focus on development of advanced neuromodulation and cardiac devices
    • 5.2.1.5 Increasing collaborations among device manufacturers, healthcare providers, and research institutes to develop neuromodulation and cardiac devices
    • 5.2.1.6 Availability of reimbursements for neuromodulation, cardiac devices, and cochlear implants
    • 5.2.1.7 Growing prevalence of hearing loss and increasing adoption of smart hearing aids
  • 5.2.2 RESTRAINTS
    • 5.2.2.1 High cost of electroceutical devices
    • 5.2.2.2 Preference for drug therapies over neuromodulation and cardiac products
    • 5.2.2.3 Adverse effects and complications associated with neuromodulation, cardiac devices, and cochlear implants
  • TABLE 3 POTENTIAL ADVERSE EFFECTS ASSOCIATED WITH DIFFERENT DEVICES
  • 5.2.3 OPPORTUNITIES
    • 5.2.3.1 Emerging markets
    • 5.2.3.2 Development of ICDs and MRI-compatible ICDs and CRT-Ds
    • 5.2.3.3 Integration with digital health platforms
  • 5.2.4 CHALLENGES
    • 5.2.4.1 Dearth of trained professionals
    • 5.2.4.2 Challenges associated with battery life and device replacement
    • 5.2.4.3 Complexity and infection issues related to electroceutical devices
  • 5.2.5 TRENDS
    • 5.2.5.1 Role of artificial intelligence (AI) in electroceutical devices
    • 5.2.5.2 Wearable and portable electroceuticals
• 5.3 PRICING ANALYSIS
  • TABLE 4 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY PRODUCT (2022)
  • TABLE 5 AVERAGE SELLING PRICE TREND FOR NEUROMODULATION DEVICES AND PROCEDURES, BY REGION (2022)
• 5.4 VALUE CHAIN ANALYSIS
  • FIGURE 20 VALUE CHAIN ANALYSIS: MAJOR VALUE ADDED DURING MANUFACTURING AND ASSEMBLY PHASES
• 5.5 SUPPLY CHAIN ANALYSIS
  • FIGURE 21 DIRECT DISTRIBUTION-PREFERRED STRATEGY FOR PROMINENT COMPANIES
• 5.6 ECOSYSTEM ANALYSIS OF ELECTROCEUTICALS MARKET
  • FIGURE 22 ELECTROCEUTICALS MARKET: ECOSYSTEM ANALYSIS
  • 5.6.1 ROLE IN ECOSYSTEM
  • TABLE 6 ELECTROCEUTICALS MARKET: ROLE IN ECOSYSTEM
  • 5.6.2 KEY PLAYERS IN ELECTROCEUTICALS MARKET
  • FIGURE 23 ELECTROCEUTICALS MARKET: KEY PLAYERS
• 5.7 PORTER'S FIVE FORCES ANALYSIS
  • TABLE 7 ELECTROCEUTICALS MARKET: PORTER'S FIVE FORCES ANALYSIS
  • 5.7.1 THREAT OF NEW ENTRANTS
  • 5.7.2 INTENSITY OF COMPETITIVE RIVALRY
  • 5.7.3 BARGAINING POWER OF BUYERS
  • 5.7.4 BARGAINING POWER OF SUPPLIERS
  • 5.7.5 THREAT OF SUBSTITUTES
• 5.8 REGULATORY LANDSCAPE
  • 5.8.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 8 INDICATIVE LIST OF REGULATORY AUTHORITIES GOVERNING ELECTROCEUTICALS MARKET
  • 5.8.2 NORTH AMERICA
    • 5.8.2.1 US
  • TABLE 9 US FDA: MEDICAL DEVICE CLASSIFICATION
  • TABLE 10 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
    • 5.8.2.2 Canada
  • TABLE 11 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
  • 5.8.3 EUROPE
  • 5.8.4 ASIA PACIFIC
    • 5.8.4.1 China
  • TABLE 12 CHINA: CLASSIFICATION OF MEDICAL DEVICES
    • 5.8.4.2 Japan
    • 5.8.4.3 India
• 5.9 TECHNOLOGY ANALYSIS
• 5.10 TRADE ANALYSIS
  • 5.10.1 IMPORT SCENARIO FOR PACEMAKERS
  • TABLE 13 IMPORT DATA FOR PACEMAKERS, BY COUNTRY, 2018-2022 (USD MILLION)
  • 5.10.2 EXPORT SCENARIO FOR PACEMAKERS
  • TABLE 14 EXPORT DATA FOR PACEMAKERS, BY COUNTRY, 2018-2022 (USD MILLION)
  • 5.10.3 IMPORT SCENARIO FOR COMPLIANT PRODUCTS
  • TABLE 15 IMPORT DATA FOR HS CODE 901890-COMPLIANT PRODUCTS, BY COUNTRY, 2018-2022 (USD MILLION)
  • 5.10.4 EXPORT SCENARIO FOR COMPLIANT PRODUCTS
  • TABLE 16 EXPORT DATA FOR HS CODE 901890-COMPLIANT PRODUCTS, BY COUNTRY, 2018-2022 (USD MILLION)
• 5.11 PATENT ANALYSIS
  • FIGURE 24 ELECTROCEUTICALS MARKET: PATENT ANALYSIS OF CARDIAC PACEMAKERS
  • FIGURE 25 ELECTROCEUTICALS MARKET: PATENT ANALYSIS OF NEUROMODULATION PRODUCTS
• 5.12 KEY CONFERENCES AND EVENTS
  • TABLE 17 LIST OF CONFERENCES & EVENTS, 2024-2025
• 5.13 TRENDS/DISRUPTIONS IMPACTING CUSTOMER'S BUSINESS
  • FIGURE 26 REVENUE SHIFT FOR ELECTROCEUTICALS MARKET
• 5.14 KEY STAKEHOLDERS AND BUYING CRITERIA
  • 5.14.1 KEY STAKEHOLDERS IN BUYING PROCESS
  • FIGURE 27 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS
  • TABLE 18 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY END USER
  • 5.14.2 BUYING CRITERIA
  • FIGURE 28 KEY BUYING CRITERIA FOR HOSPITALS

6 ELECTROCEUTICALS MARKET, BY PRODUCT

• 6.1 INTRODUCTION
  • TABLE 19 ELECTROCEUTICALS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
• 6.2 CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS
  • 6.2.1 INTRODUCTION OF LEADLESS AND MRI-SAFE PACEMAKERS & DEFIBRILLATORS TO BOOST MARKET GROWTH
  • TABLE 20 KEY PRODUCTS IN CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET
  • TABLE 21 CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY REGION, 2021-2029 (USD MILLION)
  • TABLE 22 NORTH AMERICA: CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
  • TABLE 23 EUROPE: CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
  • TABLE 24 ASIA PACIFIC: CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
  • TABLE 25 MIDDLE EAST & AFRICA: CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY REGION, 2021-2029 (USD MILLION)
• 6.3 COCHLEAR IMPLANTS
  • 6.3.1 INCREASING PREVALENCE OF HEARING LOSS TO DRIVE DEMAND
  • TABLE 26 KEY PRODUCTS IN COCHLEAR IMPLANTS MARKET
  • TABLE 27 COCHLEAR IMPLANTS MARKET, BY REGION, 2021-2029 (USD MILLION)
  • TABLE 28 NORTH AMERICA: COCHLEAR IMPLANTS MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
  • TABLE 29 EUROPE: COCHLEAR IMPLANTS MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
  • TABLE 30 ASIA PACIFIC: COCHLEAR IMPLANTS MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
  • TABLE 31 MIDDLE EAST & AFRICA: COCHLEAR IMPLANTS MARKET, BY REGION, 2021-2029 (USD MILLION)
• 6.4 NEUROMODULATORS
  • TABLE 32 NEUROMODULATORS MARKET, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 33 NEUROMODULATORS MARKET, BY REGION, 2021-2029 (USD MILLION)
  • TABLE 34 NORTH AMERICA: NEUROMODULATORS MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
  • TABLE 35 EUROPE: NEUROMODULATORS MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
  • TABLE 36 ASIA PACIFIC: NEUROMODULATORS MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
  • TABLE 37 MIDDLE EAST & AFRICA: NEUROMODULATORS MARKET, BY REGION, 2021-2029 (USD MILLION)
  • 6.4.1 SPINAL CORD STIMULATORS
    • 6.4.1.1 Growing incidence of spinal cord injuries to support market growth
  • TABLE 38 KEY SPINAL CORD STIMULATOR DEVICES AVAILABLE IN MARKET
  • TABLE 39 SPINAL CORD STIMULATORS MARKET, BY REGION, 2021-2029 (USD MILLION)
  • TABLE 40 NORTH AMERICA: SPINAL CORD STIMULATORS MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
  • TABLE 41 EUROPE: SPINAL CORD STIMULATORS MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
  • TABLE 42 ASIA PACIFIC: SPINAL CORD STIMULATORS MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
  • TABLE 43 MIDDLE EAST & AFRICA: SPINAL CORD STIMULATORS MARKET, BY REGION, 2021-2029 (USD MILLION)
  • 6.4.2 DEEP BRAIN STIMULATORS
    • 6.4.2.1 Widely used to control debilitating symptoms caused by movement and neurological disorders
  • TABLE 44 KEY DEEP BRAIN STIMULATOR DEVICES AVAILABLE IN MARKET
  • TABLE 45 DEEP BRAIN STIMULATORS MARKET, BY REGION, 2021-2029 (USD MILLION)
  • TABLE 46 NORTH AMERICA: DEEP BRAIN STIMULATORS MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
  • TABLE 47 EUROPE: DEEP BRAIN STIMULATORS MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
  • TABLE 48 ASIA PACIFIC: DEEP BRAIN STIMULATORS MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
  • TABLE 49 MIDDLE EAST & AFRICA: DEEP BRAIN STIMULATORS MARKET, BY REGION, 2021-2029 (USD MILLION)
  • 6.4.3 VAGUS NERVE STIMULATORS
    • 6.4.3.1 High incidence of epilepsy to drive market
  • TABLE 50 KEY VAGUS NERVE STIMULATOR DEVICES AVAILABLE IN MARKET
  • TABLE 51 VAGUS NERVE STIMULATORS MARKET, BY REGION, 2021-2029 (USD MILLION)
  • TABLE 52 NORTH AMERICA: VAGUS NERVE STIMULATORS MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
  • TABLE 53 EUROPE: VAGUS NERVE STIMULATORS MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
  • TABLE 54 ASIA PACIFIC: VAGUS NERVE STIMULATORS MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
  • TABLE 55 MIDDLE EAST & AFRICA: VAGUS NERVE STIMULATORS MARKET, BY REGION, 2021-2029 (USD MILLION)
  • 6.4.4 SACRAL NERVE STIMULATORS
    • 6.4.4.1 Widening scope of sacral nerve stimulation to drive growth
  • TABLE 56 KEY SACRAL NERVE STIMULATOR DEVICES AVAILABLE IN MARKET
  • TABLE 57 SACRAL NERVE STIMULATORS MARKET, BY REGION, 2021-2029 (USD MILLION)
  • TABLE 58 NORTH AMERICA: SACRAL NERVE STIMULATORS MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
  • TABLE 59 EUROPE: SACRAL NERVE STIMULATORS MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
  • TABLE 60 ASIA PACIFIC: SACRAL NERVE STIMULATORS MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
  • TABLE 61 MIDDLE EAST & AFRICA: SACRAL NERVE STIMULATORS MARKET, BY REGION, 2021-2029 (USD MILLION)
  • 6.4.5 GASTRIC ELECTRICAL STIMULATORS
    • 6.4.5.1 Growing number of people suffering from severe GERD and gastroparesis to fuel market growth
  • TABLE 62 GASTRIC ELECTRICAL STIMULATORS MARKET, BY REGION, 2021-2029 (USD MILLION)
  • TABLE 63 NORTH AMERICA: GASTRIC ELECTRICAL STIMULATORS MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
  • TABLE 64 EUROPE: GASTRIC ELECTRICAL STIMULATORS MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
  • TABLE 65 ASIA PACIFIC: GASTRIC ELECTRICAL STIMULATORS MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
  • TABLE 66 MIDDLE EAST & AFRICA: GASTRIC ELECTRICAL STIMULATORS MARKET, BY REGION, 2021-2029 (USD MILLION)
  • 6.4.6 TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS
    • 6.4.6.1 Extensive use in healthcare, low cost, and ease of use to favor market growth
  • TABLE 67 TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS MARKET, BY REGION, 2021-2029 (USD MILLION)
  • TABLE 68 NORTH AMERICA: TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
  • TABLE 69 EUROPE: TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
  • TABLE 70 ASIA PACIFIC: TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
  • TABLE 71 MIDDLE EAST & AFRICA: TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS MARKET, BY REGION, 2021-2029 (USD MILLION)
  • 6.4.7 TRANSCRANIAL MAGNETIC STIMULATORS
    • 6.4.7.1 Minimal patient discomfort associated with TMS to support demand
  • TABLE 72 TRANSCRANIAL MAGNETIC STIMULATORS MARKET, BY REGION, 2021-2029 (USD MILLION)
  • TABLE 73 NORTH AMERICA: TRANSCRANIAL MAGNETIC STIMULATORS MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
  • TABLE 74 EUROPE: TRANSCRANIAL MAGNETIC STIMULATORS MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
  • TABLE 75 ASIA PACIFIC: TRANSCRANIAL MAGNETIC STIMULATORS MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
  • TABLE 76 MIDDLE EAST & AFRICA: TRANSCRANIAL MAGNETIC STIMULATORS MARKET, BY REGION, 2021-2029 (USD MILLION)
  • 6.4.8 RESPIRATORY ELECTRICAL STIMULATORS
    • 6.4.8.1 Increasing incidence of spinal cord injuries to drive market
  • TABLE 77 RESPIRATORY ELECTRICAL STIMULATORS MARKET, BY REGION, 2021-2029 (USD MILLION)
  • TABLE 78 NORTH AMERICA: RESPIRATORY ELECTRICAL STIMULATORS MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
  • TABLE 79 EUROPE: RESPIRATORY ELECTRICAL STIMULATORS MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
  • TABLE 80 ASIA PACIFIC: RESPIRATORY ELECTRICAL STIMULATORS MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
  • TABLE 81 MIDDLE EAST & AFRICA: RESPIRATORY ELECTRICAL STIMULATORS MARKET, BY REGION, 2021-2029 (USD MILLION)
  • 6.4.9 TRIGEMINAL NERVE STIMULATORS
    • 6.4.9.1 High treatment efficacy to fuel market growth
  • TABLE 82 TRIGEMINAL NERVE STIMULATORS MARKET, BY REGION, 2021-2029 (USD MILLION)
  • TABLE 83 NORTH AMERICA: TRIGEMINAL NERVE STIMULATORS MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
  • TABLE 84 EUROPE: TRIGEMINAL NERVE STIMULATORS MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
  • TABLE 85 ASIA PACIFIC: TRIGEMINAL NERVE STIMULATORS MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
  • TABLE 86 MIDDLE EAST & AFRICA: TRIGEMINAL NERVE STIMULATORS MARKET, BY REGION, 2021-2029 (USD MILLION)
  • 6.4.10 RESPONSIVE NEUROSTIMULATORS
    • 6.4.10.1 Targeted and personalized treatment to fuel market growth
  • TABLE 87 RESPONSIVE NEUROSTIMULATORS MARKET, BY REGION, 2021-2029 (USD MILLION)
  • TABLE 88 NORTH AMERICA: RESPONSIVE NEUROSTIMULATORS MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
  • TABLE 89 EUROPE: RESPONSIVE NEUROSTIMULATORS MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
  • TABLE 90 ASIA PACIFIC: RESPONSIVE NEUROSTIMULATORS MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
  • TABLE 91 MIDDLE EAST & AFRICA: RESPONSIVE NEUROSTIMULATORS MARKET, BY REGION, 2021-2029 (USD MILLION)
• 6.5 RETINAL IMPLANTS
  • 6.5.1 GROWING NUMBER OF RETINITIS PIGMENTOSA CASES TO SUPPORT MARKET GROWTH
  • TABLE 92 RETINAL IMPLANTS MARKET, BY REGION, 2021-2029 (USD MILLION)
  • TABLE 93 NORTH AMERICA: RETINAL IMPLANTS MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
  • TABLE 94 EUROPE: RETINAL IMPLANTS MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
  • TABLE 95 ASIA PACIFIC: RETINAL IMPLANTS MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
  • TABLE 96 MIDDLE EAST & AFRICA: RETINAL IMPLANTS MARKET, BY REGION, 2021-2029 (USD MILLION)

7 ELECTROCEUTICALS MARKET, BY TYPE

• 7.1 INTRODUCTION
  • TABLE 97 ELECTROCEUTICALS MARKET, BY TYPE, 2021-2029 (USD MILLION)
• 7.2 IMPLANTABLE ELECTROCEUTICAL DEVICES
  • 7.2.1 LONG-TERM COST SAVINGS TO DRIVE MARKET
  • TABLE 98 IMPLANTABLE ELECTROCEUTICAL DEVICES MARKET, BY REGION, 2021-2029 (USD MILLION)
  • TABLE 99 NORTH AMERICA: IMPLANTABLE ELECTROCEUTICAL DEVICES MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
  • TABLE 100 EUROPE: IMPLANTABLE ELECTROCEUTICAL DEVICES MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
  • TABLE 101 ASIA PACIFIC: IMPLANTABLE ELECTROCEUTICAL DEVICES MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
  • TABLE 102 MIDDLE EAST & AFRICA: IMPLANTABLE ELECTROCEUTICAL DEVICES MARKET, BY REGION, 2021-2029 (USD MILLION)
• 7.3 NONINVASIVE ELECTROCEUTICAL DEVICES
  • 7.3.1 EXTENSIVE USE IN HEALTHCARE, EASE OF USE, AND LOW COST TO SUPPORT MARKET GROWTH
  • TABLE 103 NONINVASIVE ELECTROCEUTICAL DEVICES MARKET, BY REGION, 2021-2029 (USD MILLION)
  • TABLE 104 NORTH AMERICA: NONINVASIVE ELECTROCEUTICAL DEVICES MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
  • TABLE 105 EUROPE: NONINVASIVE ELECTROCEUTICAL DEVICES MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
  • TABLE 106 ASIA PACIFIC: NONINVASIVE ELECTROCEUTICAL DEVICES MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
  • TABLE 107 MIDDLE EAST & AFRICA: NONINVASIVE ELECTROCEUTICAL DEVICES MARKET, BY REGION, 2021-2029 (USD MILLION)

8 ELECTROCEUTICALS MARKET, BY APPLICATION

• 8.1 INTRODUCTION
• 8.2 ELECTROCEUTICALS MARKET FOR CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS (ICD), BY APPLICATION
  • TABLE 108 ELECTROCEUTICALS MARKET FOR CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY APPLICATION, 2021-2029 (USD MILLION)
  • 8.2.1 ARRHYTHMIA
    • 8.2.1.1 Increasing prevalence of arrhythmia to support market growth
  • TABLE 109 CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET FOR ARRHYTHMIA, BY REGION, 2021-2029 (USD MILLION)
  • TABLE 110 NORTH AMERICA: CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET FOR ARRHYTHMIA, BY COUNTRY, 2021-2029 (USD MILLION)
  • TABLE 111 EUROPE: CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET FOR ARRHYTHMIA, BY COUNTRY, 2021-2029 (USD MILLION)
  • TABLE 112 ASIA PACIFIC: CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET FOR ARRHYTHMIA, BY COUNTRY, 2021-2029 (USD MILLION)
  • 8.2.2 HEART FAILURE
    • 8.2.2.1 Rising prevalence of heart-related conditions in older individuals to drive growth
  • TABLE 113 CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET FOR HEART FAILURE, BY REGION, 2021-2029 (USD MILLION)
  • TABLE 114 NORTH AMERICA: CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET FOR HEART FAILURE, BY COUNTRY, 2021-2029 (USD MILLION)
  • TABLE 115 EUROPE: CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET FOR HEART FAILURE, BY COUNTRY, 2021-2029 (USD MILLION)
  • TABLE 116 ASIA PACIFIC: CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET FOR HEART FAILURE, BY COUNTRY, 2021-2029 (USD MILLION)
  • 8.2.3 OTHER CARDIAC PACEMAKER & ICD APPLICATIONS
  • TABLE 117 CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET FOR OTHER APPLICATIONS, BY REGION, 2021-2029 (USD MILLION)
  • TABLE 118 NORTH AMERICA: CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021-2029 (USD MILLION)
  • TABLE 119 EUROPE: CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021-2029 (USD MILLION)
  • TABLE 120 ASIA PACIFIC: CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021-2029 (USD MILLION)
• 8.3 ELECTROCEUTICALS MARKET FOR SPINAL CORD STIMULATORS, BY APPLICATION
  • TABLE 121 ELECTROCEUTICALS MARKET FOR SPINAL CORD STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
  • 8.3.1 CHRONIC PAIN
    • 8.3.1.1 High incidence of chronic pain to support market growth
  • TABLE 122 SPINAL CORD STIMULATORS MARKET FOR CHRONIC PAIN, BY REGION, 2021-2029 (USD MILLION)
  • TABLE 123 NORTH AMERICA: SPINAL CORD STIMULATORS MARKET FOR CHRONIC PAIN, BY COUNTRY, 2021-2029 (USD MILLION)
  • TABLE 124 EUROPE: SPINAL CORD STIMULATORS MARKET FOR CHRONIC PAIN, BY COUNTRY, 2021-2029 (USD MILLION)
  • TABLE 125 ASIA PACIFIC: SPINAL CORD STIMULATORS MARKET FOR CHRONIC PAIN, BY COUNTRY, 2021-2029 (USD MILLION)
  • 8.3.2 FAILED BACK SURGERY SYNDROME
    • 8.3.2.1 Increasing incidence of FBSS to drive demand
  • TABLE 126 SPINAL CORD STIMULATORS MARKET FOR FAILED BACK SURGERY SYNDROME, BY REGION, 2021-2029 (USD MILLION)
  • TABLE 127 NORTH AMERICA: SPINAL CORD STIMULATORS MARKET FOR FAILED BACK SURGERY SYNDROME, BY COUNTRY, 2021-2029 (USD MILLION)
  • TABLE 128 EUROPE: SPINAL CORD STIMULATORS MARKET FOR FAILED BACK SURGERY SYNDROME, BY COUNTRY, 2021-2029 (USD MILLION)
  • TABLE 129 ASIA PACIFIC: SPINAL CORD STIMULATORS MARKET FOR FAILED BACK SURGERY SYNDROME, BY COUNTRY, 2021-2029 (USD MILLION)
  • 8.3.3 ISCHEMIA
    • 8.3.3.1 High effectiveness of neuromodulation for ischemia treatment to propel market
  • TABLE 130 SPINAL CORD STIMULATORS MARKET FOR ISCHEMIA, BY REGION, 2021-2029 (USD MILLION)
  • TABLE 131 NORTH AMERICA: SPINAL CORD STIMULATORS MARKET FOR ISCHEMIA, BY COUNTRY, 2021-2029 (USD MILLION)
  • TABLE 132 EUROPE: SPINAL CORD STIMULATORS MARKET FOR ISCHEMIA, BY COUNTRY, 2021-2029 (USD MILLION)
  • TABLE 133 ASIA PACIFIC: SPINAL CORD STIMULATORS MARKET FOR ISCHEMIA, BY COUNTRY, 2021-2029 (USD MILLION)
• 8.4 ELECTROCEUTICALS MARKET FOR DEEP BRAIN STIMULATORS, BY APPLICATION
  • TABLE 134 ELECTROCEUTICALS MARKET FOR DEEP BRAIN STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
  • 8.4.1 PARKINSON'S DISEASE
    • 8.4.1.1 Rising incidence of Parkinson's disease and growing R&D to drive market
  • TABLE 135 DEEP BRAIN STIMULATORS MARKET FOR PARKINSON'S DISEASE, BY REGION, 2021-2029 (USD MILLION)
  • TABLE 136 NORTH AMERICA: DEEP BRAIN STIMULATORS MARKET FOR PARKINSON'S DISEASE, BY COUNTRY, 2021-2029 (USD MILLION)
  • TABLE 137 EUROPE: DEEP BRAIN STIMULATORS MARKET FOR PARKINSON'S DISEASE, BY COUNTRY, 2021-2029 (USD MILLION)
  • TABLE 138 ASIA PACIFIC: DEEP BRAIN STIMULATORS MARKET FOR PARKINSON'S DISEASE, BY COUNTRY, 2021-2029 (USD MILLION)
  • 8.4.2 TREMORS
    • 8.4.2.1 High efficacy of DBS in treating tremors to drive market
  • TABLE 139 DEEP BRAIN STIMULATORS MARKET FOR TREMORS, BY REGION, 2021-2029 (USD MILLION)
  • TABLE 140 NORTH AMERICA: DEEP BRAIN STIMULATORS MARKET FOR TREMORS, BY COUNTRY, 2021-2029 (USD MILLION)
  • TABLE 141 EUROPE: DEEP BRAIN STIMULATORS MARKET FOR TREMORS, BY COUNTRY, 2021-2029 (USD MILLION)
  • TABLE 142 ASIA PACIFIC: DEEP BRAIN STIMULATORS MARKET FOR TREMORS, BY COUNTRY, 2021-2029 (USD MILLION)
  • 8.4.3 DEPRESSION
    • 8.4.3.1 Rising research and clinical studies related to depression treatment to propel market
  • TABLE 143 DEEP BRAIN STIMULATORS MARKET FOR DEPRESSION, BY REGION, 2021-2029 (USD MILLION)
  • TABLE 144 NORTH AMERICA: DEEP BRAIN STIMULATORS MARKET FOR DEPRESSION, BY COUNTRY, 2021-2029 (USD MILLION)
  • TABLE 145 EUROPE: DEEP BRAIN STIMULATORS MARKET FOR DEPRESSION, BY COUNTRY, 2021-2029 (USD MILLION)
  • TABLE 146 ASIA PACIFIC: DEEP BRAIN STIMULATORS MARKET FOR DEPRESSION, BY COUNTRY, 2021-2029 (USD MILLION)
  • 8.4.4 OTHER DBS APPLICATIONS
  • TABLE 147 DEEP BRAIN STIMULATORS MARKET FOR OTHER APPLICATIONS, BY REGION, 2021-2029 (USD MILLION)
  • TABLE 148 NORTH AMERICA: DEEP BRAIN STIMULATORS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021-2029 (USD MILLION)
  • TABLE 149 EUROPE: DEEP BRAIN STIMULATORS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021-2029 (USD MILLION)
  • TABLE 150 ASIA PACIFIC: DEEP BRAIN STIMULATORS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021-2029 (USD MILLION)
• 8.5 ELECTROCEUTICALS MARKET FOR SACRAL NERVE STIMULATORS, BY APPLICATION
  • TABLE 151 ELECTROCEUTICALS MARKET FOR SACRAL NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
  • 8.5.1 URINE INCONTINENCE
    • 8.5.1.1 High incidence of urine incontinence to offer growth opportunities for market players
  • TABLE 152 SACRAL NERVE STIMULATORS MARKET FOR URINE INCONTINENCE, BY REGION, 2021-2029 (USD MILLION)
  • TABLE 153 NORTH AMERICA: SACRAL NERVE STIMULATORS MARKET FOR URINE INCONTINENCE, BY COUNTRY, 2021-2029 (USD MILLION)
  • TABLE 154 EUROPE: SACRAL NERVE STIMULATORS MARKET FOR URINE INCONTINENCE, BY COUNTRY, 2021-2029 (USD MILLION)
  • TABLE 155 ASIA PACIFIC: SACRAL NERVE STIMULATORS MARKET FOR URINE INCONTINENCE, BY COUNTRY, 2021-2029 (USD MILLION)
  • 8.5.2 FECAL INCONTINENCE
    • 8.5.2.1 Reduced symptom recurrence with use of SNS to drive demand
  • TABLE 156 SACRAL NERVE STIMULATORS MARKET FOR FECAL INCONTINENCE, BY REGION, 2021-2029 (USD MILLION)
  • TABLE 157 NORTH AMERICA: SACRAL NERVE STIMULATORS MARKET FOR FECAL INCONTINENCE, BY COUNTRY, 2021-2029 (USD MILLION)
  • TABLE 158 EUROPE: SACRAL NERVE STIMULATORS MARKET FOR FECAL INCONTINENCE, BY COUNTRY, 2021-2029 (USD MILLION)
  • TABLE 159 ASIA PACIFIC: SACRAL NERVE STIMULATORS MARKET FOR FECAL INCONTINENCE, BY COUNTRY, 2021-2029 (USD MILLION)
• 8.6 ELECTROCEUTICALS MARKET FOR VAGUS NERVE STIMULATORS, BY APPLICATION
  • TABLE 160 ELECTROCEUTICALS MARKET FOR VAGUS NERVE SIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
  • 8.6.1 EPILEPSY
    • 8.6.1.1 Advantages associated with VNS in epilepsy treatment to propel market
  • TABLE 161 VAGUS NERVE STIMULATORS MARKET FOR EPILEPSY, BY REGION, 2021-2029 (USD MILLION)
  • TABLE 162 NORTH AMERICA: VAGUS NERVE STIMULATORS MARKET FOR EPILEPSY, BY COUNTRY, 2021-2029 (USD MILLION)
  • TABLE 163 EUROPE: VAGUS NERVE STIMULATORS MARKET FOR EPILEPSY, BY COUNTRY, 2021-2029 (USD MILLION)
  • TABLE 164 ASIA PACIFIC: VAGUS NERVE STIMULATORS MARKET FOR EPILEPSY, BY COUNTRY, 2021-2029 (USD MILLION)
  • 8.6.2 OTHER VNS APPLICATIONS
  • TABLE 165 VAGUS NERVE STIMULATORS MARKET FOR OTHER APPLICATIONS, BY REGION, 2021-2029 (USD MILLION)
  • TABLE 166 NORTH AMERICA: VAGUS NERVE STIMULATORS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021-2029 (USD MILLION)
  • TABLE 167 EUROPE: VAGUS NERVE STIMULATORS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021-2029 (USD MILLION)
  • TABLE 168 ASIA PACIFIC: VAGUS NERVE STIMULATORS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021-2029 (USD MILLION)
• 8.7 ELECTROCEUTICALS MARKET FOR GASTRIC ELECTRICAL STIMULATORS, BY APPLICATION
  • TABLE 169 ELECTROCEUTICALS MARKET FOR GASTRIC ELECTRICAL STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
  • 8.7.1 GASTROPARESIS
    • 8.7.1.1 Reduced hospitalization time associated with GES treatment to drive market
  • TABLE 170 GASTRIC ELECTRICAL STIMULATORS MARKET FOR GASTROPARESIS, BY REGION, 2021-2029 (USD MILLION)
  • TABLE 171 NORTH AMERICA: GASTRIC ELECTRICAL STIMULATORS MARKET FOR GASTROPARESIS, BY COUNTRY, 2021-2029 (USD MILLION)
  • TABLE 172 EUROPE: GASTRIC ELECTRICAL STIMULATORS MARKET FOR GASTROPARESIS, BY COUNTRY, 2021-2029 (USD MILLION)
  • TABLE 173 ASIA PACIFIC: GASTRIC ELECTRICAL STIMULATORS MARKET FOR GASTROPARESIS, BY COUNTRY, 2021-2029 (USD MILLION)
  • 8.7.2 OBESITY
    • 8.7.2.1 High prevalence of obesity and risks associated with gastric bypass to propel market
  • TABLE 174 GASTRIC ELECTRICAL STIMULATORS MARKET FOR OBESITY, BY REGION, 2021-2029 (USD MILLION)
  • TABLE 175 NORTH AMERICA: GASTRIC ELECTRICAL STIMULATORS MARKET FOR OBESITY, BY COUNTRY, 2021-2029 (USD MILLION)
  • TABLE 176 EUROPE: GASTRIC ELECTRICAL STIMULATORS MARKET FOR OBESITY, BY COUNTRY, 2021-2029 (USD MILLION)
  • TABLE 177 ASIA PACIFIC: GASTRIC ELECTRICAL STIMULATORS MARKET FOR OBESITY, BY COUNTRY, 2021-2029 (USD MILLION)
• 8.8 ELECTROCEUTICALS MARKET FOR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS, BY APPLICATION
  • TABLE 178 ELECTROCEUTICALS MARKET FOR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
  • 8.8.1 TREATMENT-RESISTANT DEPRESSION
    • 8.8.1.1 High prevalence of depression to drive market
  • TABLE 179 TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS MARKET FOR TREATMENT-RESISTANT DEPRESSION, BY REGION, 2021-2029 (USD MILLION)
  • TABLE 180 NORTH AMERICA: TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS MARKET FOR TREATMENT-RESISTANT DEPRESSION, BY COUNTRY, 2021-2029 (USD MILLION)
  • TABLE 181 EUROPE: TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS MARKET FOR TREATMENT-RESISTANT DEPRESSION, BY COUNTRY, 2021-2029 (USD MILLION)
  • TABLE 182 ASIA PACIFIC: TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS MARKET FOR TREATMENT-RESISTANT DEPRESSION, BY COUNTRY, 2021-2029 (USD MILLION)
  • 8.8.2 OTHER TENS APPLICATIONS
  • TABLE 183 TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS MARKET FOR OTHER APPLICATIONS, BY REGION, 2021-2029 (USD MILLION)
  • TABLE 184 NORTH AMERICA: TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS MARKET FOR OTHER APPLICATIONS, 2021-2029 (USD MILLION)
  • TABLE 185 EUROPE: TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021-2029 (USD MILLION)
  • TABLE 186 ASIA PACIFIC: TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021-2029 (USD MILLION)
• 8.9 ELECTROCEUTICALS MARKET FOR TRANSCRANIAL MAGNETIC STIMULATORS, BY APPLICATION
  • TABLE 187 ELECTROCEUTICALS MARKET FOR TRANSCRANIAL MAGNETIC STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION
  • 8.9.1 DEPRESSION
    • 8.9.1.1 High effectiveness of TMS and increased acceptance among patients to drive market
  • TABLE 188 TRANSCRANIAL MAGNETIC STIMULATORS MARKET FOR DEPRESSION, BY REGION, 2021-2029 (USD MILLION)
  • TABLE 189 NORTH AMERICA: TRANSCRANIAL MAGNETIC STIMULATORS MARKET FOR DEPRESSION, BY COUNTRY, 2021-2029 (USD MILLION)
  • TABLE 190 EUROPE: TRANSCRANIAL MAGNETIC STIMULATORS MARKET FOR DEPRESSION, BY COUNTRY, 2021-2029 (USD MILLION)
  • TABLE 191 ASIA PACIFIC: TRANSCRANIAL MAGNETIC STIMULATORS MARKET FOR DEPRESSION, BY COUNTRY, 2021-2029 (USD MILLION)
  • 8.9.2 MIGRAINE
    • 8.9.2.1 High prevalence of migraine to support market growth
  • TABLE 192 TRANSCRANIAL MAGNETIC STIMULATORS MARKET FOR MIGRAINE, BY REGION, 2021-2029 (USD MILLION)
  • TABLE 193 NORTH AMERICA: TRANSCRANIAL MAGNETIC STIMULATORS MARKET FOR MIGRAINE, BY COUNTRY, 2021-2029 (USD MILLION)
  • TABLE 194 EUROPE: TRANSCRANIAL MAGNETIC STIMULATORS MARKET FOR MIGRAINE, BY COUNTRY, 2021-2029 (USD MILLION)
  • TABLE 195 ASIA PACIFIC: TRANSCRANIAL MAGNETIC STIMULATORS MARKET FOR MIGRAINE, BY COUNTRY, 2021-2029 (USD MILLION)
• 8.10 ELECTROCEUTICALS MARKET FOR RESPIRATORY ELECTRICAL STIMULATORS, BY APPLICATION
  • 8.10.1 SPINAL CORD INJURY
    • 8.10.1.1 Rising incidence of spinal cord injuries to fuel demand
  • TABLE 196 RESPIRATORY ELECTRICAL STIMULATORS MARKET FOR SPINAL CORD INJURY, BY REGION, 2021-2029 (USD MILLION)
• 8.11 ELECTROCEUTICALS MARKET FOR TRIGEMINAL NERVE STIMULATORS, BY APPLICATION
  • TABLE 197 ELECTROCEUTICALS MARKET FOR TRIGEMINAL NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION
  • 8.11.1 ATTENTION-DEFICIT/HYPERACTIVITY DISORDER
    • 8.11.1.1 Minimal side effects to drive adoption
  • TABLE 198 TRIGEMINAL NERVE STIMULATORS MARKET FOR ATTENTION-DEFICIT/HYPERACTIVITY DISORDER, BY REGION, 2021-2029 (USD MILLION)
  • TABLE 199 NORTH AMERICA: TRIGEMINAL NERVE STIMULATORS MARKET FOR ATTENTION-DEFICIT/HYPERACTIVITY DISORDER, BY COUNTRY, 2021-2029 (USD MILLION)
  • TABLE 200 EUROPE: TRIGEMINAL NERVE STIMULATORS MARKET FOR ATTENTION-DEFICIT/HYPERACTIVITY DISORDER, BY COUNTRY, 2021-2029 (USD MILLION)
  • TABLE 201 ASIA PACIFIC: TRIGEMINAL NERVE STIMULATORS MARKET FOR ATTENTION-DEFICIT/HYPERACTIVITY DISORDER, BY COUNTRY, 2021-2029 (USD MILLION)
  • 8.11.2 MIGRAINE
    • 8.11.2.1 Increasing demand for non-pharmacological treatments to support market growth
  • TABLE 202 TRIGEMINAL NERVE STIMULATORS MARKET FOR MIGRAINE, BY REGION, 2021-2029 (USD MILLION)
  • TABLE 203 NORTH AMERICA: TRIGEMINAL NERVE STIMULATORS MARKET FOR MIGRAINE, BY COUNTRY, 2021-2029 (USD MILLION)
  • TABLE 204 EUROPE: TRIGEMINAL NERVE STIMULATORS MARKET FOR MIGRAINE, BY COUNTRY, 2021-2029 (USD MILLION)
  • TABLE 205 ASIA PACIFIC: TRIGEMINAL NERVE STIMULATORS MARKET FOR MIGRAINE, BY COUNTRY, 2021-2029 (USD MILLION)

9 ELECTROCEUTICALS MARKET, BY REGION

• 9.1 INTRODUCTION
  • TABLE 206 ELECTROCEUTICALS MARKET, BY REGION, 2021-2029 (USD MILLION)
• 9.2 NORTH AMERICA
  • FIGURE 29 NORTH AMERICA: ELECTROCEUTICALS MARKET SNAPSHOT
  • TABLE 207 NORTH AMERICA: ELECTROCEUTICALS MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
  • TABLE 208 NORTH AMERICA: ELECTROCEUTICALS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
  • TABLE 209 NORTH AMERICA: NEUROMODULATORS MARKET, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 210 NORTH AMERICA: ELECTROCEUTICALS MARKET, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 211 NORTH AMERICA: ELECTROCEUTICALS MARKET FOR CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY APPLICATION, 2021-2029 (USD MILLION)
  • TABLE 212 NORTH AMERICA: ELECTROCEUTICALS MARKET FOR SPINAL CORD STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
  • TABLE 213 NORTH AMERICA: ELECTROCEUTICALS MARKET FOR DEEP BRAIN STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
  • TABLE 214 NORTH AMERICA: ELECTROCEUTICALS MARKET FOR SACRAL NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
  • TABLE 215 NORTH AMERICA: ELECTROCEUTICALS MARKET FOR VAGUS NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
  • TABLE 216 NORTH AMERICA: ELECTROCEUTICALS MARKET FOR GASTRIC ELECTRICAL STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
  • TABLE 217 NORTH AMERICA: ELECTROCEUTICALS MARKET FOR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
  • TABLE 218 NORTH AMERICA: ELECTROCEUTICALS MARKET FOR TRANSCRANIAL MAGNETIC STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
  • TABLE 219 NORTH AMERICA: ELECTROCEUTICALS MARKET FOR TRIGEMINAL NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
  • 9.2.1 US
    • 9.2.1.1 Rising prevalence of cardiovascular and neurological disorders to drive market
  • TABLE 220 US: ELECTROCEUTICALS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
  • TABLE 221 US: NEUROMODULATORS MARKET, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 222 US: ELECTROCEUTICALS MARKET, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 223 US: ELECTROCEUTICALS MARKET FOR CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY APPLICATION, 2021-2029 (USD MILLION)
  • TABLE 224 US: ELECTROCEUTICALS MARKET FOR SPINAL CORD STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
  • TABLE 225 US: ELECTROCEUTICALS MARKET FOR DEEP BRAIN STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
  • TABLE 226 US: ELECTROCEUTICALS MARKET FOR SACRAL NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
  • TABLE 227 US: ELECTROCEUTICALS MARKET FOR VAGUS NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
  • TABLE 228 US: ELECTROCEUTICALS MARKET FOR GASTRIC ELECTRICAL STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
  • TABLE 229 US: ELECTROCEUTICALS MARKET FOR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
  • TABLE 230 US: ELECTROCEUTICALS MARKET FOR TRANSCRANIAL MAGNETIC STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
  • TABLE 231 US: ELECTROCEUTICALS MARKET FOR TRIGEMINAL NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
  • 9.2.2 CANADA
    • 9.2.2.1 Rising healthcare expenditure and increasing prevalence of chronic diseases to drive demand
  • TABLE 232 NEUROLOGICAL CONDITIONS PREVALENT IN CANADA, 2016-2031
  • TABLE 233 CANADA: ELECTROCEUTICALS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
  • TABLE 234 CANADA: NEUROMODULATORS MARKET, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 235 CANADA: ELECTROCEUTICALS MARKET, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 236 CANADA: ELECTROCEUTICALS MARKET FOR CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY APPLICATION, 2021-2029 (USD MILLION)
  • TABLE 237 CANADA: ELECTROCEUTICALS MARKET FOR SPINAL CORD STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
  • TABLE 238 CANADA: ELECTROCEUTICALS MARKET FOR DEEP BRAIN STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
  • TABLE 239 CANADA: ELECTROCEUTICALS MARKET FOR SACRAL NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
  • TABLE 240 CANADA: ELECTROCEUTICALS MARKET FOR VAGUS NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
  • TABLE 241 CANADA: ELECTROCEUTICALS MARKET FOR GASTRIC ELECTRICAL STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
  • TABLE 242 CANADA: ELECTROCEUTICALS MARKET FOR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
  • TABLE 243 CANADA: ELECTROCEUTICALS MARKET FOR TRANSCRANIAL MAGNETIC STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
  • TABLE 244 CANADA: ELECTROCEUTICALS MARKET FOR TRIGEMINAL NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
  • 9.2.3 NORTH AMERICA: RECESSION IMPACT
• 9.3 EUROPE
  • TABLE 245 EUROPE: ELECTROCEUTICALS MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
  • TABLE 246 EUROPE: ELECTROCEUTICALS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
  • TABLE 247 EUROPE: NEUROMODULATORS MARKET, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 248 EUROPE: ELECTROCEUTICALS MARKET, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 249 EUROPE: ELECTROCEUTICALS MARKET FOR CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY APPLICATION, 2021-2029 (USD MILLION)
  • TABLE 250 EUROPE: ELECTROCEUTICALS MARKET FOR SPINAL CORD STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
  • TABLE 251 EUROPE: ELECTROCEUTICALS MARKET FOR DEEP BRAIN STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
  • TABLE 252 EUROPE: ELECTROCEUTICALS MARKET FOR SACRAL NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
  • TABLE 253 EUROPE: ELECTROCEUTICALS MARKET FOR VAGUS NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
  • TABLE 254 EUROPE: ELECTROCEUTICALS MARKET FOR GASTRIC ELECTRICAL STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
  • TABLE 255 EUROPE: ELECTROCEUTICALS MARKET FOR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
  • TABLE 256 EUROPE: ELECTROCEUTICALS MARKET FOR TRANSCRANIAL MAGNETIC STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
  • TABLE 257 EUROPE: ELECTROCEUTICALS MARKET FOR TRIGEMINAL NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
  • 9.3.1 GERMANY
    • 9.3.1.1 Presence of favorable reimbursement policies to drive market
  • TABLE 258 GERMANY: ELECTROCEUTICALS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
  • TABLE 259 GERMANY: NEUROMODULATORS MARKET, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 260 GERMANY: ELECTROCEUTICALS MARKET, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 261 GERMANY: ELECTROCEUTICALS MARKET FOR CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY APPLICATION, 2021-2029 (USD MILLION)
  • TABLE 262 GERMANY: ELECTROCEUTICALS MARKET FOR SPINAL CORD STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
  • TABLE 263 GERMANY: ELECTROCEUTICALS MARKET FOR DEEP BRAIN STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
  • TABLE 264 GERMANY: ELECTROCEUTICALS MARKET FOR SACRAL NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
  • TABLE 265 GERMANY: ELECTROCEUTICALS MARKET FOR VAGUS NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
  • TABLE 266 GERMANY: ELECTROCEUTICALS MARKET FOR GASTRIC ELECTRICAL STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
  • TABLE 267 GERMANY: ELECTROCEUTICALS MARKET FOR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
  • TABLE 268 GERMANY: ELECTROCEUTICALS MARKET FOR TRANSCRANIAL MAGNETIC STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
  • TABLE 269 GERMANY: ELECTROCEUTICALS MARKET FOR TRIGEMINAL NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
  • 9.3.2 UK
    • 9.3.2.1 Rising support from government and private organizations to fuel market growth
  • TABLE 270 UK: ELECTROCEUTICALS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
  • TABLE 271 UK: NEUROMODULATORS MARKET, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 272 UK: ELECTROCEUTICALS MARKET, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 273 UK: ELECTROCEUTICALS MARKET FOR CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY APPLICATION, 2021-2029 (USD MILLION)
  • TABLE 274 UK: ELECTROCEUTICALS MARKET FOR SPINAL CORD STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
  • TABLE 275 UK: ELECTROCEUTICALS MARKET FOR DEEP BRAIN STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
  • TABLE 276 UK: ELECTROCEUTICALS MARKET FOR SACRAL NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
  • TABLE 277 UK: ELECTROCEUTICALS MARKET FOR VAGUS NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
  • TABLE 278 UK: ELECTROCEUTICALS MARKET FOR GASTRIC ELECTRICAL STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
  • TABLE 279 UK: ELECTROCEUTICALS MARKET FOR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
  • TABLE 280 UK: ELECTROCEUTICALS MARKET FOR TRANSCRANIAL MAGNETIC STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
  • TABLE 281 UK: ELECTROCEUTICALS MARKET FOR TRIGEMINAL NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
  • 9.3.3 FRANCE
    • 9.3.3.1 Promising healthcare reforms to drive market
  • TABLE 282 FRANCE: ELECTROCEUTICALS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
  • TABLE 283 FRANCE: NEUROMODULATORS MARKET, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 284 FRANCE: ELECTROCEUTICALS MARKET, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 285 FRANCE: ELECTROCEUTICALS MARKET FOR CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY APPLICATION, 2021-2029 (USD MILLION)
  • TABLE 286 FRANCE: ELECTROCEUTICALS MARKET FOR SPINAL CORD STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
  • TABLE 287 FRANCE: ELECTROCEUTICALS MARKET FOR DEEP BRAIN STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
  • TABLE 288 FRANCE: ELECTROCEUTICALS MARKET FOR SACRAL NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
  • TABLE 289 FRANCE: ELECTROCEUTICALS MARKET FOR VAGUS NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
  • TABLE 290 FRANCE: ELECTROCEUTICALS MARKET FOR GASTRIC ELECTRICAL STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
  • TABLE 291 FRANCE: ELECTROCEUTICALS MARKET FOR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
  • TABLE 292 FRANCE: ELECTROCEUTICALS MARKET FOR TRANSCRANIAL MAGNETIC STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
  • TABLE 293 FRANCE: ELECTROCEUTICALS MARKET FOR TRIGEMINAL NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
  • 9.3.4 ITALY
    • 9.3.4.1 Easy access to healthcare services to create lucrative opportunities for market growth
  • TABLE 294 ITALY: ELECTROCEUTICALS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
  • TABLE 295 ITALY: NEUROMODULATORS MARKET, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 296 ITALY: ELECTROCEUTICALS MARKET, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 297 ITALY: ELECTROCEUTICALS MARKET FOR CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY APPLICATION, 2021-2029 (USD MILLION)
  • TABLE 298 ITALY: ELECTROCEUTICALS MARKET FOR SPINAL CORD STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
  • TABLE 299 ITALY: ELECTROCEUTICALS MARKET FOR DEEP BRAIN STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
  • TABLE 300 ITALY: ELECTROCEUTICALS MARKET FOR SACRAL NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
  • TABLE 301 ITALY: ELECTROCEUTICALS MARKET FOR VAGUS NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
  • TABLE 302 ITALY: ELECTROCEUTICALS MARKET FOR GASTRIC ELECTRICAL STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
  • TABLE 303 ITALY: ELECTROCEUTICALS MARKET FOR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
  • TABLE 304 ITALY: ELECTROCEUTICALS MARKET FOR TRANSCRANIAL MAGNETIC STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
  • TABLE 305 ITALY: ELECTROCEUTICALS MARKET FOR TRIGEMINAL NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
  • 9.3.5 SPAIN
    • 9.3.5.1 Increasing number of conferences and awareness programs to support market growth
  • TABLE 306 SPAIN: ELECTROCEUTICALS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
  • TABLE 307 SPAIN: NEUROMODULATORS MARKET, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 308 SPAIN: ELECTROCEUTICALS MARKET, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 309 SPAIN: ELECTROCEUTICALS MARKET FOR CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY APPLICATION, 2021-2029 (USD MILLION)
  • TABLE 310 SPAIN: ELECTROCEUTICALS MARKET FOR SPINAL CORD STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
  • TABLE 311 SPAIN: ELECTROCEUTICALS MARKET FOR DEEP BRAIN STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
  • TABLE 312 SPAIN: ELECTROCEUTICALS MARKET FOR SACRAL NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
  • TABLE 313 SPAIN: ELECTROCEUTICALS MARKET FOR VAGUS NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
  • TABLE 314 SPAIN: ELECTROCEUTICALS MARKET FOR GASTRIC ELECTRICAL STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
  • TABLE 315 SPAIN: ELECTROCEUTICALS MARKET FOR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
  • TABLE 316 SPAIN: ELECTROCEUTICALS MARKET FOR TRANSCRANIAL MAGNETIC STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
  • TABLE 317 SPAIN: ELECTROCEUTICALS MARKET FOR TRIGEMINAL NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
  • 9.3.6 REST OF EUROPE
  • TABLE 318 REST OF EUROPE: ELECTROCEUTICALS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
  • TABLE 319 REST OF EUROPE: NEUROMODULATORS MARKET, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 320 REST OF EUROPE: ELECTROCEUTICALS MARKET, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 321 REST OF EUROPE: ELECTROCEUTICALS MARKET FOR CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY APPLICATION, 2021-2029 (USD MILLION)
  • TABLE 322 REST OF EUROPE: ELECTROCEUTICALS MARKET FOR SPINAL CORD STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
  • TABLE 323 REST OF EUROPE: ELECTROCEUTICALS MARKET FOR DEEP BRAIN STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
  • TABLE 324 REST OF EUROPE: ELECTROCEUTICALS MARKET FOR SACRAL NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
  • TABLE 325 REST OF EUROPE: ELECTROCEUTICALS MARKET FOR VAGUS NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
  • TABLE 326 REST OF EUROPE: ELECTROCEUTICALS MARKET FOR GASTRIC ELECTRICAL STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
  • TABLE 327 REST OF EUROPE: ELECTROCEUTICALS MARKET FOR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
  • TABLE 328 REST OF EUROPE: ELECTROCEUTICALS MARKET FOR TRANSCRANIAL MAGNETIC STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
  • TABLE 329 REST OF EUROPE: ELECTROCEUTICALS MARKET FOR TRIGEMINAL NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
  • 9.3.7 EUROPE: RECESSION IMPACT
• 9.4 ASIA PACIFIC
  • FIGURE 30 ASIA PACIFIC: ELECTROCEUTICALS MARKET SNAPSHOT
  • TABLE 330 ASIA PACIFIC: ELECTROCEUTICALS MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
  • TABLE 331 ASIA PACIFIC: ELECTROCEUTICALS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
  • TABLE 332 ASIA PACIFIC: NEUROMODULATORS MARKET, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 333 ASIA PACIFIC: ELECTROCEUTICALS MARKET, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 334 ASIA PACIFIC: ELECTROCEUTICALS MARKET FOR CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY APPLICATION, 2021-2029 (USD MILLION)
  • TABLE 335 ASIA PACIFIC: ELECTROCEUTICALS MARKET FOR SPINAL CORD STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
  • TABLE 336 ASIA PACIFIC: ELECTROCEUTICALS MARKET FOR DEEP BRAIN STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
  • TABLE 337 ASIA PACIFIC: ELECTROCEUTICALS MARKET FOR SACRAL NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
  • TABLE 338 ASIA PACIFIC: ELECTROCEUTICALS MARKET FOR VAGUS NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
  • TABLE 339 ASIA PACIFIC: ELECTROCEUTICALS MARKET FOR GASTRIC ELECTRICAL STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
  • TABLE 340 ASIA PACIFIC: ELECTROCEUTICALS MARKET FOR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
  • TABLE 341 ASIA PACIFIC: ELECTROCEUTICALS MARKET FOR TRANSCRANIAL MAGNETIC STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
  • TABLE 342 ASIA PACIFIC: ELECTROCEUTICALS MARKET FOR TRIGEMINAL NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
  • 9.4.1 JAPAN
    • 9.4.1.1 Increasing prevalence of cardiovascular and neurological disorders to drive demand
  • TABLE 343 JAPAN: ELECTROCEUTICALS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
  • TABLE 344 JAPAN: NEUROMODULATORS MARKET, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 345 JAPAN: ELECTROCEUTICALS MARKET, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 346 JAPAN: ELECTROCEUTICALS MARKET FOR CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY APPLICATION, 2021-2029 (USD MILLION)
  • TABLE 347 JAPAN: ELECTROCEUTICALS MARKET FOR SPINAL CORD STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
  • TABLE 348 JAPAN: ELECTROCEUTICALS MARKET FOR DEEP BRAIN STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
  • TABLE 349 JAPAN: ELECTROCEUTICALS MARKET FOR SACRAL NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
  • TABLE 350 JAPAN: ELECTROCEUTICALS MARKET FOR VAGUS NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
  • TABLE 351 JAPAN: ELECTROCEUTICALS MARKET FOR GASTRIC ELECTRICAL STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
  • TABLE 352 JAPAN: ELECTROCEUTICALS MARKET FOR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
  • TABLE 353 JAPAN: ELECTROCEUTICALS MARKET FOR TRANSCRANIAL MAGNETIC STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
  • TABLE 354 JAPAN: ELECTROCEUTICALS MARKET FOR TRIGEMINAL NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
  • 9.4.2 CHINA
    • 9.4.2.1 Rising geriatric population to support market growth
  • TABLE 355 CHINA: ELECTROCEUTICALS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
  • TABLE 356 CHINA: NEUROMODULATORS MARKET, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 357 CHINA: ELECTROCEUTICALS MARKET, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 358 CHINA: ELECTROCEUTICALS MARKET FOR CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY APPLICATION, 2021-2029 (USD MILLION)
  • TABLE 359 CHINA: ELECTROCEUTICALS MARKET FOR SPINAL CORD STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
  • TABLE 360 CHINA: ELECTROCEUTICALS MARKET FOR DEEP BRAIN STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
  • TABLE 361 CHINA: ELECTROCEUTICALS MARKET FOR SACRAL NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
  • TABLE 362 CHINA: ELECTROCEUTICALS MARKET FOR VAGUS NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
  • TABLE 363 CHINA: ELECTROCEUTICALS MARKET FOR GASTRIC ELECTRICAL STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
  • TABLE 364 CHINA: ELECTROCEUTICALS MARKET FOR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
  • TABLE 365 CHINA: ELECTROCEUTICALS MARKET FOR TRANSCRANIAL MAGNETIC STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
  • TABLE 366 CHINA: ELECTROCEUTICALS MARKET FOR TRIGEMINAL NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
  • 9.4.3 INDIA
    • 9.4.3.1 Developments in healthcare structure to propel market
  • TABLE 367 INDIA: ELECTROCEUTICALS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
  • TABLE 368 INDIA: NEUROMODULATORS MARKET, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 369 INDIA: ELECTROCEUTICALS MARKET, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 370 INDIA: ELECTROCEUTICALS MARKET FOR CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY APPLICATION, 2021-2029 (USD MILLION)
  • TABLE 371 INDIA: ELECTROCEUTICALS MARKET FOR SPINAL CORD STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
  • TABLE 372 INDIA: ELECTROCEUTICALS MARKET FOR DEEP BRAIN STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
  • TABLE 373 INDIA: ELECTROCEUTICALS MARKET FOR SACRAL NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
  • TABLE 374 INDIA: ELECTROCEUTICALS MARKET FOR VAGUS NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
  • TABLE 375 INDIA: ELECTROCEUTICALS MARKET FOR GASTRIC ELECTRICAL STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
  • TABLE 376 INDIA: ELECTROCEUTICALS MARKET FOR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
  • TABLE 377 INDIA: ELECTROCEUTICALS MARKET FOR TRANSCRANIAL MAGNETIC STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
  • TABLE 378 INDIA: ELECTROCEUTICALS MARKET FOR TRIGEMINAL NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
  • 9.4.4 REST OF ASIA PACIFIC
  • TABLE 379 REST OF ASIA PACIFIC: ELECTROCEUTICALS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
  • TABLE 380 REST OF ASIA PACIFIC: NEUROMODULATORS MARKET, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 381 REST OF ASIA PACIFIC: ELECTROCEUTICALS MARKET, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 382 REST OF ASIA PACIFIC: ELECTROCEUTICALS MARKET FOR CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY APPLICATION, 2021-2029 (USD MILLION)
  • TABLE 383 REST OF ASIA PACIFIC: ELECTROCEUTICALS MARKET FOR SPINAL CORD STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
  • TABLE 384 REST OF ASIA PACIFIC: ELECTROCEUTICALS MARKET FOR DEEP BRAIN STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
  • TABLE 385 REST OF ASIA PACIFIC: ELECTROCEUTICALS MARKET FOR SACRAL NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
  • TABLE 386 REST OF ASIA PACIFIC: ELECTROCEUTICALS MARKET FOR VAGUS NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
  • TABLE 387 REST OF ASIA PACIFIC: ELECTROCEUTICALS MARKET FOR GASTRIC ELECTRICAL STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
  • TABLE 388 REST OF ASIA PACIFIC: ELECTROCEUTICALS MARKET FOR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
  • TABLE 389 REST OF ASIA PACIFIC: ELECTROCEUTICALS MARKET FOR TRANSCRANIAL MAGNETIC STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
  • TABLE 390 REST OF ASIA PACIFIC: ELECTROCEUTICALS MARKET FOR TRIGEMINAL NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
  • 9.4.5 ASIA PACIFIC: RECESSION IMPACT
• 9.5 LATIN AMERICA
  • 9.5.1 RAPIDLY GROWING GERIATRIC POPULATION TO SUPPORT MARKET GROWTH
  • TABLE 391 LATIN AMERICA: ELECTROCEUTICALS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
  • TABLE 392 LATIN AMERICA: NEUROMODULATORS MARKET, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 393 LATIN AMERICA: ELECTROCEUTICALS MARKET, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 394 LATIN AMERICA: ELECTROCEUTICALS MARKET FOR CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY APPLICATION, 2021-2029 (USD MILLION)
  • TABLE 395 LATIN AMERICA: ELECTROCEUTICALS MARKET FOR SPINAL CORD STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
  • TABLE 396 LATIN AMERICA: ELECTROCEUTICALS MARKET FOR DEEP BRAIN STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
  • TABLE 397 LATIN AMERICA: ELECTROCEUTICALS MARKET FOR SACRAL NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
  • TABLE 398 LATIN AMERICA: ELECTROCEUTICALS MARKET FOR VAGUS NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
  • TABLE 399 LATIN AMERICA: ELECTROCEUTICALS MARKET FOR GASTRIC ELECTRICAL STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
  • TABLE 400 LATIN AMERICA: ELECTROCEUTICALS MARKET FOR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
  • TABLE 401 LATIN AMERICA: ELECTROCEUTICALS MARKET FOR TRANSCRANIAL MAGNETIC STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
  • TABLE 402 LATIN AMERICA: ELECTROCEUTICALS MARKET FOR TRIGEMINAL NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
  • 9.5.2 LATIN AMERICA: RECESSION IMPACT
• 9.6 MIDDLE EAST & AFRICA
  • TABLE 403 MIDDLE EAST & AFRICA: ELECTROCEUTICALS MARKET, BY REGION, 2021-2029 (USD MILLION)
  • TABLE 404 MIDDLE EAST & AFRICA: ELECTROCEUTICALS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
  • TABLE 405 MIDDLE EAST & AFRICA: NEUROMODULATORS MARKET, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 406 MIDDLE EAST & AFRICA: ELECTROCEUTICALS MARKET, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 407 MIDDLE EAST & AFRICA: ELECTROCEUTICALS MARKET FOR CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY APPLICATION, 2021-2029 (USD MILLION)
  • TABLE 408 MIDDLE EAST & AFRICA: ELECTROCEUTICALS MARKET FOR SPINAL CORD STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
  • TABLE 409 MIDDLE EAST & AFRICA: ELECTROCEUTICALS MARKET FOR DEEP BRAIN STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
  • TABLE 410 MIDDLE EAST & AFRICA: ELECTROCEUTICALS MARKET FOR SACRAL NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
  • TABLE 411 MIDDLE EAST & AFRICA: ELECTROCEUTICALS MARKET FOR VAGUS NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
  • TABLE 412 MIDDLE EAST & AFRICA: ELECTROCEUTICALS MARKET FOR GASTRIC ELECTRICAL STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
  • TABLE 413 MIDDLE EAST & AFRICA: ELECTROCEUTICALS MARKET FOR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
  • TABLE 414 MIDDLE EAST & AFRICA: ELECTROCEUTICALS MARKET FOR TRANSCRANIAL MAGNETIC STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
  • TABLE 415 MIDDLE EAST & AFRICA: ELECTROCEUTICALS MARKET FOR TRIGEMINAL NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
  • 9.6.1 GCC COUNTRIES
    • 9.6.1.1 Advances in healthcare sector to support market growth
  • TABLE 416 GCC COUNTRIES: ELECTROCEUTICALS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
  • TABLE 417 GCC COUNTRIES: NEUROMODULATORS MARKET, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 418 GCC COUNTRIES: ELECTROCEUTICALS MARKET, BY TYPE, 2021-2029 (USD MILLION)
  • 9.6.2 REST OF MIDDLE EAST & AFRICA
  • TABLE 419 REST OF MIDDLE EAST & AFRICA: ELECTROCEUTICALS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
  • TABLE 420 REST OF MIDDLE EAST & AFRICA: NEUROMODULATORS MARKET, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 421 REST OF MIDDLE EAST & AFRICA: ELECTROCEUTICALS MARKET, BY TYPE, 2021-2029 (USD MILLION)
  • 9.6.3 MIDDLE EAST & AFRICA: RECESSION IMPACT

10 COMPETITIVE LANDSCAPE

• 10.1 OVERVIEW
• 10.2 STRATEGIES ADOPTED BY KEY PLAYERS/RIGHT TO WIN
  • TABLE 422 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS
• 10.3 REVENUE ANALYSIS
  • FIGURE 31 REVENUE ANALYSIS OF KEY PLAYERS IN ELECTROCEUTICALS MARKET
• 10.4 MARKET SHARE ANALYSIS
  • TABLE 423 ELECTROCEUTICALS MARKET: DEGREE OF COMPETITION
• 10.5 BRAND/PRODUCT COMPARISON
  • FIGURE 32 ELECTROCEUTICALS MARKET: BRAND COMPARISON, BY KEY PLAYER
• 10.6 COMPANY EVALUATION MATRIX: KEY PLAYERS
  • 10.6.1 STARS
  • 10.6.2 EMERGING LEADERS
  • 10.6.3 PERVASIVE PLAYERS
  • 10.6.4 PARTICIPANTS
  • FIGURE 33 ELECTROCEUTICALS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2022
• 10.7 COMPANY FOOTPRINT
  • TABLE 424 PRODUCT FOOTPRINT
  • TABLE 425 REGIONAL FOOTPRINT
  • TABLE 426 OVERALL COMPANY FOOTPRINT
• 10.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES
  • 10.8.1 PROGRESSIVE COMPANIES
  • 10.8.2 STARTING BLOCKS
  • 10.8.3 RESPONSIVE COMPANIES
  • 10.8.4 DYNAMIC COMPANIES
  • FIGURE 34 ELECTROCEUTICALS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/ SMES), 2022
• 10.9 COMPETITIVE BENCHMARKING
  • TABLE 427 ELECTROCEUTICALS MARKET: DETAILED LIST OF KEY STARTUPS/SMES
  • TABLE 428 PRODUCT FOOTPRINT (STARTUPS/SMES)
  • TABLE 429 REGIONAL FOOTPRINT (STARTUPS/SMES)
  • TABLE 430 OVERALL COMPANY FOOTPRINT (STARTUPS/SMES)
• 10.10 COMPETITIVE SCENARIO
  • 10.10.1 PRODUCT LAUNCHES & APPROVALS
  • TABLE 431 PRODUCT LAUNCHES & APPROVALS
  • 10.10.2 DEALS
  • TABLE 432 DEALS

11 COMPANY PROFILES

• (Business Overview, Products/Solutions/Services Offered, Recent Developments, MnM view (Key strengths/Right to win, Strategic choices made, Weakness/competitive threats)**
• 11.1 KEY PLAYERS
  • 11.1.1 MEDTRONIC
  • TABLE 433 MEDTRONIC: BUSINESS OVERVIEW
  • FIGURE 35 MEDTRONIC: COMPANY SNAPSHOT (2023)
  • 11.1.2 BOSTON SCIENTIFIC CORPORATION
  • TABLE 434 BOSTON SCIENTIFIC CORPORATION: BUSINESS OVERVIEW
  • FIGURE 36 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2022)
  • 11.1.3 ABBOTT
  • TABLE 435 ABBOTT: BUSINESS OVERVIEW
  • FIGURE 37 ABBOTT: COMPANY SNAPSHOT (2022)
  • 11.1.4 LIVANOVA PLC
  • TABLE 436 LIVANOVA PLC: BUSINESS OVERVIEW
  • FIGURE 38 LIVANOVA PLC: COMPANY SNAPSHOT (2022)
  • 11.1.5 COCHLEAR LTD.
  • TABLE 437 COCHLEAR LTD.: BUSINESS OVERVIEW
  • FIGURE 39 COCHLEAR LTD.: COMPANY SNAPSHOT (2023)
  • 11.1.6 MICROPORT SCIENTIFIC CORPORATION
  • TABLE 438 MICROPORT SCIENTIFIC CORPORATION: BUSINESS OVERVIEW
  • FIGURE 40 MICROPORT SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2022)
  • 11.1.7 SONOVA
  • TABLE 439 SONOVA: BUSINESS OVERVIEW
  • FIGURE 41 SONOVA GROUP: COMPANY SNAPSHOT (2022)
  • 11.1.8 NEVRO CORP.
  • TABLE 440 NEVRO CORP.: BUSINESS OVERVIEW
  • FIGURE 42 NEVRO CORP.: COMPANY SNAPSHOT (2022)
  • 11.1.9 AXONICS, INC.
  • TABLE 441 AXONICS, INC.: BUSINESS OVERVIEW
  • FIGURE 43 AXONICS INC.: COMPANY SNAPSHOT (2022)
  • 11.1.10 NEURONETICS
  • TABLE 442 NEURONETICS: BUSINESS OVERVIEW
  • FIGURE 44 NEURONETICS: COMPANY SNAPSHOT (2022)
  • 11.1.11 ELECTROCORE, INC.
  • TABLE 443 ELECTROCORE, INC.: BUSINESS OVERVIEW
  • FIGURE 45 ELECTROCORE, INC.: COMPANY SNAPSHOT (2022)
  • 11.1.12 NEUROPACE, INC.
  • TABLE 444 NEUROPACE, INC.: BUSINESS OVERVIEW
  • FIGURE 46 NEUROPACE, INC.: COMPANY SNAPSHOT (2022)
• 11.2 OTHER PLAYERS
  • 11.2.1 BIOTRONIK
  • TABLE 445 BIOTRONIK: COMPANY OVERVIEW
  • 11.2.2 MEDICO S.R.L.
  • TABLE 446 MEDICO S.R.L.: COMPANY OVERVIEW
  • 11.2.3 ZHEJIANG NUROTRON BIOTECHNOLOGY CO., LTD.
  • TABLE 447 ZHEJIANG NUROTRON BIOTECHNOLOGY CO., LTD.: COMPANY OVERVIEW
  • 11.2.4 MED-EL
  • TABLE 448 MED-EL: COMPANY OVERVIEW
  • 11.2.5 ALEVA NEUROTHERAPEUTICS
  • TABLE 449 ALEVA NEUROTHERAPEUTICS: COMPANY OVERVIEW
  • 11.2.6 NEUROSIGMA, INC.
  • TABLE 450 NEUROSIGMA, INC.: COMPANY OVERVIEW
  • 11.2.7 BIOWAVE CORPORATION
  • TABLE 451 BIOWAVE CORPORATION: COMPANY OVERVIEW
  • 11.2.8 SOTERIX MEDICAL INC.
  • TABLE 452 SOTERIX MEDICAL INC.: COMPANY OVERVIEW
  • 11.2.9 BIOINDUCTION (AMBER THERAPEUTICS)
  • TABLE 453 BIOINDUCTION (AMBER THERAPEUTICS): COMPANY OVERVIEW
  • 11.2.10 GIMER MEDICAL
  • TABLE 454 GIMER MEDICAL: COMPANY OVERVIEW
  • 11.2.11 CEFALY
  • TABLE 455 CEFALY: COMPANY OVERVIEW
  • 11.2.12 BIOCONTROL MEDICAL
  • TABLE 456 BIOCONTROL MEDICAL: COMPANY OVERVIEW
  • 11.2.13 TVNS HEALTH GMBH
  • TABLE 457 TVNS HEALTH GMBH: COMPANY OVERVIEW
• *Details on Business Overview, Products/Solutions/Services Offered, Recent Developments, MnM view (Key strengths/Right to win, Strategic choices made, Weakness/competitive threats)** might not be captured in case of unlisted companies.

12 APPENDIX

• 12.1 DISCUSSION GUIDE
• 12.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
• 12.3 CUSTOMIZATION OPTIONS
• 12.4 RELATED REPORTS
• 12.5 AUTHOR DETAILS

관련자료